ABVC BioPharma (ABVC) Income Statement: Revenue & Earnings

ABVC BioPharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

ABVC BioPharma, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.51	0.15	0.97	0.36	0.48
Cost of Revenue	0.00	0.30	0.29	0.01	0.02
Gross Profit	0.51	-0.15	0.68	0.35	0.46
Operating Expenses
Research & Development	0.18	1.06	2.69	1.00	0.55
Selling, General & Administrative	5.03	5.55	13.10	5.75	4.27
Operating Expenses	5.21	6.62	15.80	12.06	8.97
Operating Income	-4.71	-6.77	-15.11	-11.71	-8.51
Other Income/Expense
Interest Income	0.09	0.19	0.19	0.04	0.07
Interest Expense	0.83	1.31	0.29	-0.23	-0.41
Other Income/Expense	0.07	-0.13	-0.29	0.16	0.20
Income
Income Before Tax	-5.37	-8.02	-15.51	-11.21	-10.81
Income Tax Expense	-0.11	0.26	0.80	0.83	-0.22
Net Income	-4.90	-7.79	-16.42	-12.84	-9.79
Net Income - Continuous Operations	-5.26	-8.28	-16.31	-12.04	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-4.34	-6.33	-15.20	-11.69	-8.47
EBIT	-4.54	-6.71	-15.22	-11.71	-8.51
Depreciation & Amortization	0.20	0.38	0.02	0.01	0.04
Earnings Per Share
Basic EPS	-	-2.00	-5.00	-5.00	-5.00
Diluted EPS	-	-2.00	-5.00	-5.00	-5.00
Basic Shares Outstanding	11.67	4.34	3.17	2.51	1.97
Diluted Shares Outstanding	11.67	4.34	3.17	2.51	1.97